Back to top

Image: Bigstock

Cigna Corp.

Read MoreHide Full Article

Cigna’s pending merger with Anthem is facing friction with the regulators and the company is now engaged in a legal tussle of the same. The deal, which would have helped the company to gain the leading position in the industry, now remains uncertain.  Forex volatility, share buyback suspension, merger-related charges will drain the bottom line going forward.  An underperforming Disability and life business also raises concerns. Also restriction imposed by the CMS on the sale of Medicare Advantage plan is a headwind. Nonetheless, the company is poised for long-term growth from its superior performing Global Supplemental business, growing Government business and increasing membership. A strong capital position is another positive.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Cigna Corporation (CI) - free report >>

Published in